CDChristophe Duvoux
Christophe Duvoux
*This is an algorithmically generated author record based on publicly available information.
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Christophe Duvoux has a total of 264 co-authors. Here are the top co-authors by number of shared publications:
D Dhumeaux
15 shared publications- Daniel Cherqui
Service de Chirurgie Générale et Digestive, Hôpital Henri-Mondor, Créteil
11 shared publications - Georges-Philippe Pageaux
Hepato-gastroenterology Department, CHU Saint Eloi, Montpellier University
10 shared publications - Jérôme Dumortier
Hospices civils de Lyon, Edouard Herriot hospital, Department of Digestive Diseases, Lyon, France; Claude Bernard Lyon 1 University, Lyon, France
9 shared publications P L Fagniez
9 shared publicationsS. Radenne
9 shared publications
Latest Publications
- 1 January 2017
- Published by Elsevier in Journal of Hepatology
- Vol. 66 (1) , S200
Factors associated with tumor recurrence after liver transplantation for hepatocellular carcinoma: prospective cohort on 371 patients
- 1 January 2017
- Published by Elsevier in Journal of Hepatology
- Vol. 66 (1) , S200
Factors associated with tumor recurrence after liver transplantation for hepatocellular carcinoma: prospective cohort on 371 patients
- 1 January 2017
- Published by Elsevier in Journal of Hepatology
- Vol. 66 (1) , S39-S40
Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study
- 1 January 2017
- Published by Elsevier in Journal of Hepatology
- Vol. 66 (1) , S39-S40
Delisting of liver transplant candidates with chronic hepatitis C virus infection after viral eradication: outcome after delisting: a European study
- 1 January 2016
- Published by Elsevier in Journal of Hepatology
- Vol. 64 (2) , S551
Sofosbuvir-Based-Regimen for HCV Recurrence after Combined Liver-Kidney Transplantation : Results from the ANRS CO23 Cupilt Study
- 1 January 2016
- Published by Elsevier in Journal of Hepatology
- Vol. 64 (2) , S551
Sofosbuvir-Based-Regimen for HCV Recurrence after Combined Liver-Kidney Transplantation : Results from the ANRS CO23 Cupilt Study
- 1 January 2016
- Published by Elsevier in Journal of Hepatology
- Vol. 64 (2) , S144-S145
Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study
- 1 January 2016
- Published by Elsevier in Journal of Hepatology
- Vol. 64 (2) , S144-S145
Should we keep using Ribavirin to Treat Hepatitis C Recurrence after Liver Transplantation? Results from the CO23 ANRS Cupilt Study
- 1 January 2016
- Published by Elsevier in Journal of Hepatology
- Vol. 64 (2) , S533
Validation of 2 Explant-Based Recurrence Prognostic Models after Liver Transplantation for Hepatocellular Carcinoma in an External Cohort
- 1 January 2016
- Published by Elsevier in Journal of Hepatology
- Vol. 64 (2) , S533
Validation of 2 Explant-Based Recurrence Prognostic Models after Liver Transplantation for Hepatocellular Carcinoma in an External Cohort
- 1 April 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62, S247-S248
O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study
- 1 April 2015
- Published by Elsevier in Journal of Hepatology
- Vol. 62, S247-S248
O109 : Treatment of severe HCV-recurrence after liver transplantation using sofosbuvir-based regimens: The ANRS CO23 CUPILT study
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S380
P915 PREDICTION OF RECURRENCE AFTER LIVER TRANSPLANTATION FOR HCC: VALIDATION OF THE AFP MODEL IN AN ITALIAN COHORT
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S380
P915 PREDICTION OF RECURRENCE AFTER LIVER TRANSPLANTATION FOR HCC: VALIDATION OF THE AFP MODEL IN AN ITALIAN COHORT
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S371-S372
P892 PREVALENCE OF DONOR SPECIFIC ANTIBODIES IN LIVER TRANSPLANTATION RECIPIENTS WITH UNEXPLAINED LIVER GRAFT ABNORMALITIES IS SIGNIFICANTLY HIGHER THAN IN CONTROL GROUPS
- 1 April 2014
- Published by Elsevier in Journal of Hepatology
- Vol. 60 (1) , S371-S372
P892 PREVALENCE OF DONOR SPECIFIC ANTIBODIES IN LIVER TRANSPLANTATION RECIPIENTS WITH UNEXPLAINED LIVER GRAFT ABNORMALITIES IS SIGNIFICANTLY HIGHER THAN IN CONTROL GROUPS